Rondo news

News and Events

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Rondo secures Series A funding

News

March 2, 2022

Rondo Therapeutics Closes $67 Million Series A

Events

April 8, 2025

Rondo Therapeutics Publishes Preclinical Data on RNDO-564 in Journal for ImmunoTherapy of Cancer

Events

February 10, 2025

Rondo Presents Preclinical Data at ASCO GU

News

December 4, 2024

Rondo Announces Collaboration with Lilly

News

November 19, 2024

Thomas Manley, MD, Joins Rondo as new CMO

News

July 2, 2024

Steven James, Joins Rondo's Board of Directors

News

May 15, 2024

Rondo Therapeutics to Showcase Next-Generation CD28 Bispecific Platform

Events

March 26, 2024

Pear Biotech Bench to Business Podcast

Events

December 26, 2023

Timmerman Podcast

SITE

HomeAboutSciencePipelineContact

Contact

info@rondotx.com 25801 Industrial Blvd.
Ste. 500
Hayward, CA 94545

Social

Policy

Terms of usePrivacy policy

© 2024 Rondo Therapeutics. All rights reserved.